Mymaa Pharmaceuticals Private Limited
About Mymaa Pharmaceuticals Private Limited
Data last updated:
Mymaa Pharmaceuticals Private Limited is a private limited company based in Allahabad, Uttar Pradesh, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 01 November 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24290UP2022PTC172878.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prashant Kumar Pandey and Janardan Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Allahabad, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.19 Lakh. For the same year it recorded a net profit of ₹10,697 (net margin 1.2%) and EBITDA of ₹10,697 (EBITDA margin 1.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mymaa Pharmaceuticals Private Limited's registered office is in Allahabad, Uttar Pradesh.
- Registered Address92/1, Sohbatiya Bagh, Allahabad, Uttar Pradesh, India – 211006
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mymaa Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Mymaa Pharmaceuticals Private Limited, buy the company report.
Financials of Mymaa Pharmaceuticals Private Limited
FY 2025 filings availableMymaa Pharmaceuticals Private Limited reported revenue of ₹9.19 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹10,697 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹10,697 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.2% | ||
| Net Profit Margin | 1.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Mymaa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mymaa Pharmaceuticals Private Limited
Mymaa Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashant Kumar Pandey | Director | 01 Nov 2022 | 4 Years 0 Months | Current |
| Janardan Singh | Director | 14 Feb 2024 | 2 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Mymaa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mymaa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mymaa Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mymaa Pharmaceuticals Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Dilip Omprakash Ojha ceased to be Director on 14 Feb 2024.
Frequently asked questions
Mymaa Pharmaceuticals is an active private limited company based in Allahabad, Uttar Pradesh, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 01 November 2022 (4+ years old) and is registered under CIN U24290UP2022PTC172878.
Mymaa Pharmaceuticals has 2 current directors:
- Prashant Kumar Pandey - Director
- Janardan Singh - Director
The latest financial statements of Mymaa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Mymaa Pharmaceuticals is U24290UP2022PTC172878. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mymaa Pharmaceuticals was incorporated on 01 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Dilip Omprakash Ojha ceased to be Director on 14 Feb 2024. Janardan Singh was appointed as Director on 14 Feb 2024. Prashant Kumar Pandey was appointed as Director on 01 Nov 2022.
The registered office of Mymaa Pharmaceuticals is at 921, Sohbatiya Bagh, Allahabad, Uttar Pradesh, India – 211006.
Mymaa Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.
The compliance status of Mymaa Pharmaceuticals is compliant as of 04 July 2026. The company is actively filing with the Registrar of Companies.
Mymaa Pharmaceuticals can be reached at its registered office: 921, Sohbatiya Bagh, Allahabad, Uttar Pradesh, India – 211006.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
